Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Currently accepted at: JMIR Research Protocols

Date Submitted: Dec 8, 2025
Date Accepted: Nov 16, 2026

This paper has been accepted and is currently in production.

It will appear shortly on 10.2196/89184

The final accepted version (not copyedited yet) is in this tab.

Multimodal Diagnostics in Post-COVID: protocol of a matched-pair case-control study

  • Andreas Posa; 
  • Walter Alexander Wohlgemuth; 
  • Alexander Gussew; 
  • Anne Slawig; 
  • Lars Reinhardt; 
  • Andreas Deistung; 
  • Maik Rothe; 
  • Andrii Starenkyi; 
  • Stefan Schob; 
  • Heidi Hellmann; 
  • Alexander Kranz; 
  • Rafael Mikolajczyk; 
  • Andreas Wienke; 
  • Laura Rebecca Pfrommer; 
  • Stephan Eisenmann; 
  • Nina Lambrecht; 
  • Tess Nunez Quiroga; 
  • Matthias Girndt; 
  • Anja Lahr; 
  • Frank Bernhard Kraus; 
  • Stephan Schulze; 
  • René Schwesig; 
  • Christian Dubau; 
  • Matthias Kappler; 
  • Ole Hensel

ABSTRACT

Background:

Post-COVID (PC) syndrome affects 10–35% of individuals after SARS-CoV-2 infection, presenting with fatigue, dizziness, cognitive dysfunction, cardiac symptoms, and post-exertional malaise. Its pathophysiology remains poorly understood, with evidence implicating chronic inflammation, microvascular impairment, mitochondrial dysfunction, and autonomic dysregulation.

Objective:

The aim is to identify objective pathophysiological correlates of PC through comprehensive, multimodal assessments across microvascular, mitochondrial, and multi-organ functions.

Methods:

We designed a single-center, cross-sectional matched case-control study to investigate PC pathophysiology. Sixty-one participants with PC and 61 age- and sex-matched controls will undergo two consecutive days of multimodal assessments. Evaluations include advanced MRI of the brain, heart, lungs, and skeletal muscle; phosphorus-31 magnetic resonance spectroscopy; near-infrared spectroscopy; surface electromyography; critical flicker fusion frequency testing; video nailfold capillaroscopy; echocardiography including heart rate variability; body plethysmogra-phy; cardiopulmonary exercise testing; and laboratory analyses. This protocol enables simultaneous assessment of microvascular structure and function, mitochondrial energetics, and multi-organ dysfunction.

Results:

This methods manuscript describes the feasibility, implementation, and reproducibility of the protocol, including recruitment strategies, data acquisition workflows, and quality control procedures. Planned analyses will allow identification of objective pathophysiological correlates of PC.

Conclusions:

This comprehensive protocol provides a framework to study multi-organ dysfunction in PC. By integrating imaging, physiological, and laboratory assessments, it aims to generate objective biomarkers, improve risk stratification, reduce patient stigmatization, and inform evidence-based therapies for this complex syndrome affecting millions worldwide. Clinical Trial: German Register of Clinical Studies (DRKS; ID: DRKS00036987


 Citation

Please cite as:

Posa A, Wohlgemuth WA, Gussew A, Slawig A, Reinhardt L, Deistung A, Rothe M, Starenkyi A, Schob S, Hellmann H, Kranz A, Mikolajczyk R, Wienke A, Pfrommer LR, Eisenmann S, Lambrecht N, Quiroga TN, Girndt M, Lahr A, Kraus FB, Schulze S, Schwesig R, Dubau C, Kappler M, Hensel O

Multimodal Diagnostics in Post-COVID: protocol of a matched-pair case-control study

JMIR Research Protocols. 16/11/2026:89184 (forthcoming/in press)

DOI: 10.2196/89184

URL: https://preprints.jmir.org/preprint/89184

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.